Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Mar;92(3):302–308. doi: 10.1111/j.1349-7006.2001.tb01095.x

Progesterone Receptor A and B Isoforms in the Human Breast and Its Disorders

Naohiro Ariga 1,2,✉, Takashi Suzuki 1, Takuya Moriya 1, Michio Kimura 3, Tsukasa Inoue 1, Noriaki Ohuchi 2, Hironobu Sasano 1
PMCID: PMC5926716  PMID: 11267940

Abstract

Two different isoforms of progesterone receptor (PR), PRA and PRB, are expressed in target tissues at comparable levels. In this study, we first examined PRA and PRB immunoreactivity in human breast cancer and various intraductal proliferative epithelial lesions, and correlated these findings with clinicopathologic parameters. We then examined mRNA expression of PRA and PRB in six cases of invasive ductal carcinoma using RT‐PCR. Immunoreactivity for both PRA and PRB was positive in the great majority of proliferative disease without atypia (PDWA) (85% for PRA and 96% for PRB) and atypical ductal hyperplasia (ADH) (100% for PRA and 100% for PRB), but the ratio of immunopositive cases and immunohistochemical (IHC) scores was significantly smaller in ductal carcinoma in situ (DCIS) (65% for PRA and 75% for PRB) and invasive ductal carcinoma (IDC) (66% for PRA and 55% for PRB) than in PDWA and ADH. There was a significant positive correlation between IHC scores for PRA and estrogen receptor α (ERα) in IDC, DCIS and ADH but not between PRB and ERα. In IDC, both PRA and PRB IHC scores were significantly associated with histological grade, but there was no association between PRA or PRB status and lymph node involvement, tumor size, or prognosis of the patients. The expression of mRNAs for both PRA and PRB was detected in all six cases of IDC examined. These results suggest that both PRA and PRB are strongly associated with ERa in human breast and this relation may be disturbed in breast cancer.

Keywords: Progesterone receptor A, Progesterone receptor B, Breast, Carcinoma, Immunohistochemistry

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

References

  • 1.Horwitz , K. B. . and Alexander , P. S.In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation . Endocrinology , 113 , 2195 – 2201 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 2.Kastner , P. , Krust , A. , Turcotte , B. , Stropp , U. , Tora , L. , Gronemeyer , H. . and Chambon , P.Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B . EMBO J. , 9 , 1603 – 1614 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.McGowan , E. M. . and Clarke , C. L.Effect of overexpression of progesterone receptor A on endogenous progestin‐sensitive endpoints in breast cancer cells . Mol. Endocrinol. , 13 , 1657 – 1671 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 4.Graham , J. D. , Yeates , C. , Balleine , R. L. , Harvey , S. S. , Milliken , J. S. , Bilous , A. M. . and Clarke , C. L.Characterization of progesterone receptor A and B expression in human breast cancer . Cancer Res. , 55 , 5063 – 5068 ( 1995. ). [PubMed] [Google Scholar]
  • 5.Dupont , W. D. . and Page , D. L.Risk factors for breast cancer in women with proliferative breast disease . N. Engl. J. Med. , 312 , 146 – 151 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 6.Ottesen , G. L. , Graverson , H. P. , Blichert‐Toft , M. , Zeldeler , K. . and Andersen , J. A.Ductal carcinoma in situ of the female breast: short‐term results of a prospective nationwide study . Am. J. Surg. Pathol. , 16 , 1183 – 1196 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 7.The Consensus Conference Committee . Consensus conference on the classification of ductal carcinoma in situ . Cancer , 80 , 1798 – 1802 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 8.Elston , C. W. . and Ellis , I. O.Pathological prognosis factors in breast cancer. I. The value of histopathological grade in breast cancer: experience from a large study with long‐term follow‐up . Histopathology , 19 , 403 – 410 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 9.Wyss‐Desserich , M. T. , Caduff‐Joos , R. , Wyss , P. , Rageth , C. , Wight , E. , Unger , C. , Walt , H. . and Haller , U.Premenopausal node‐negative breast cancer: may adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics ? Breast Cancer Res. Treat. , 42 , 253 – 263 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 10.Zhang , G. J. , Kimijima , I. , Abe , R. , Watanabe , T. , Kanno , M. , Hara , K. . and Tsuchiya , A.Apoptotic index correlates to bcl‐2 and p53 protein expression, histological grade and prognosis in invasive breast cancers . Anticancer Res. , 18 , 1989 – 1998 ( 1998. ). [PubMed] [Google Scholar]
  • 11.Silverstein , M. J. , Poller , D. N. . and Waisman , J. R.Prognostic classification of breast ductal carcinoma in situ . Lancet , 345 , 1154 – 1157 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 12.Douglas‐Jones , A. G. , Gupta , S. K. , Attanoos , R. L. , Morgan , J. M. . and Mansel , R. E.A critical appraisal of six modern classification of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma . Histopathology , 29 , 397 – 409 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 13.Clarke , C. L. , Zaino , R. J. , Feil , P. D. , Miller , J. V. , Steck , M. E. , Ohlsson‐Wilhelm , B. M. . and Satyaswaroop , P. G.Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques . Endocrinology , 121 , 1123 – 1132 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 14.Mote , P. A. , Balleine , R. L. , McGowan , E. M. . and Clarke , C. L.Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle . J. Clin. Endocrinol. Metab. , 84 , 2963 – 2971 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 15.Gray , G. O. . and Satyaswaroop , P. G.Species crossreactivity of human progesterone receptor monoclonal antibodies: western blot analysis . Biochem. Biophys. Res. Commun. , 157 , 1067 – 1077 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 16.Allred , D. C. , Harvey , J. H. , Berardo , M. . and Clark , G. M.Prognostic and predictive factors in breast cancer by immunohistochemical analysis . Mod. Pathol. , 11 , 155 – 168 ( 1998. ). [PubMed] [Google Scholar]
  • 17.Harvey , J. M. , Clark , G. M. , Osborne , C. K. . and Allred , D. C.Estrogen receptor status by immunohistochemistry is superior to the ligand‐binding assay for predicting response to adjuvant endocrine therapy in breast cancer . J. Clin. Oncol. , 17 , 1474 – 1481 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 18.Sambrook , J. , Fritsch , E. F. . and Maniatis , T.Extraction, purification and analysis of messenger RNA from eukaryotic cells . In“Molecular Cloning: A Laboratory Manual ,” 2nd Ed. ( 1989. ). Cold Spring Harbor Laboratory Press; , Cold Spring Harbor , NY . [Google Scholar]
  • 19.Kumer , N. S. , Richer , J. , Owen , G. , Litman , E. , Horwitz , K. B. . and Leslie , K. K.Selective down‐regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action . Cancer Res. , 58 , 1860 – 1865 ( 1998. ). [PubMed] [Google Scholar]
  • 20.Willey , J. C. , Crawford , E. L. , Jackson , C. M. , Weaver , D. A. , Hoban , J. C. , Khuder , S. A. . and DeMuth , J. P.Expression measurement of many genes simultaneously by quantitative RT‐PCR using standardized mixtures of competitive templates . Am. J. Respir. Cell Mol. Biol. , 19 , 6 – 17 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 21.Tung , L. , Mohamed , M. K. , Hoeffler , J. P. , Takimoto , G. S. . and Horwitz , K. B.Antagonist‐occupied human progesterone B‐receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A‐receptors . Mol. Endocrinol. , 7 , 1256 – 1265 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 22.McDonnell , D. P. . and Goldman , M. E.RU486 exerts anti‐estrogenic activities through a novel progesterone receptor A‐form mediated mechanism . J. Biol. Chem. , 296 , 11945 – 11949 ( 1994. ). [PubMed] [Google Scholar]
  • 23.Chalbos , D. . and Galtier , F.Differential effect of forms A and B of human progesterone receptor on estradiol‐dependent transcription . J. Biol. Chem. , 269 , 23007 – 23012 ( 1994. ). [PubMed] [Google Scholar]
  • 24.Wen , D. X. , Xu , Y.‐F. , Mais , D. E. , Goldman , M. E. . and McDonnell , D. P.The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells . Mol. Cell. Biol. , 14 , 8356 – 8364 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Vegeto , E. , Shahbaz , M. M. , Wen , D. X. , Goldman , M. E. , O'Malley , B. W. . and McDonnell , D. P.Human progesterone receptor A form is a cell‐ and promoter‐specific represser of human progesterone receptor B function . Mol. Endocrinol. , 7 , 1244 – 1255 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 26.Adriaenssens , E. , Lottin , S. , Dugimont , T. , Fauquette , W. , Coll , J. , Dupouy , J. P. , Boilly , B. . and Curgy , J. J.Steroid hormones modulate H19 gene expression in both mammary gland and uterus . Oncogene , 18 , 4460 – 4473 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 27.Akahira , J. , Inoue , T. , Suzuki , T. , Ito , K. , Konno , R. , Shinji , S. , Moriya , T. , Okamura , K. , Yajima , A. . and Sasano , H.Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT‐PCR studies . Br. J. Cancer , 83 , 1488 – 1494 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Petz , L. N. . and Nardulli , A. M.Spl binding sites and an estrogen response element half‐site are involved in regulation of the human progesterone receptor A promoter . Mol. Endocrinol. , 14 , 972 – 985 ( 2000. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES